NCT03210025View on ClinicalTrials.gov

Clinical Bioequivalence Study on Two Methyldopa Tablet 250mg Formulations

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

September 20, 2017

Primary Completion Date

October 15, 2017

Study Completion Date

October 15, 2017

Conditions
Healthy
Interventions
DRUG

BF-Methyldopa 250mg Tablet

BF-Methyldopa 250mg Tablet is a generic product manufactured by Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited

DRUG

Metopa Tab 250mg

Metopa Tab 250mg is manufactured by APT

Trial Locations (1)

Unknown

Phase 1 Clinical Trial Centre, The Chinese University of Hong Kong, Hong Kong

All Listed Sponsors
collaborator

Chinese University of Hong Kong

OTHER

lead

Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited

INDUSTRY

NCT03210025 - Clinical Bioequivalence Study on Two Methyldopa Tablet 250mg Formulations | Biotech Hunter | Biotech Hunter